You are preparing for a Tuberculin (Mantoux) skin test for a client suspected of having TB. The nurse knows that the test will reveal which of these?

Appeared in: IGNOU Post B. SC. Nursing entrance-2019

Explanation

The Mantoux test is a delayed-type hypersensitivity skin test used to determine if a person has been infected with Mycobacterium tuberculosis.
A positive reaction, indicated by a measured area of induration, signifies that the person's immune system has been sensitized to the TB bacterium at some point in their life.
This sensitization can be due to a current active infection, a past resolved infection, or a latent (inactive) infection.
Crucially, the test itself does not differentiate between these states; it only indicates that an infection has occurred.

Option A: The Mantoux test provides no information about the duration of the infection. It is a qualitative test (yes/no for infection) based on the immune response, not a quantitative measure of time.
Option B: A positive Mantoux test does not confirm an active infection. Individuals with latent TB will also have a positive test. To diagnose active TB, further investigations like a chest X-ray, symptom evaluation, and sputum analysis (smear, culture, or NAAT) are required.
Option C: While a person with a latent infection will have a positive Mantoux test, the test itself cannot confirm the infection is latent. It cannot distinguish a latent state from an active one. The diagnosis of latent TB is one of exclusion, made after active disease has been ruled out in an asymptomatic person with a positive TST or IGRA.

Clinical Relevance

Nursing practice connection: Use the key finding related to Interpretation of Tuberculin (Mantoux) Skin Test to guide bedside assessment, documentation, and the next nursing action.
A positive Mantoux test is a screening result, not a diagnosis of active disease. Nurses must educate patients that a positive test requires further evaluation to determine if treatment for latent or active TB is needed.
Accurate administration (intradermal injection to form a wheal) and reading (measuring only induration at 48-72 hours) are critical for the test's validity. Incorrect technique can lead to false results and inappropriate clinical decisions.
What if the patient has a history of BCG vaccination? The BCG vaccine can cause a false-positive Mantoux test reaction. In such cases, or for patients who may not return for a reading, an Interferon-Gamma Release Assay (IGRA) blood test (e.g., QuantiFERON-TB Gold) is preferred as it is not affected by prior BCG vaccination.

How to Approach the Question

First, identify the core of the question: What information does the Mantoux test provide?
Recall the purpose of the Mantoux test. It is a screening tool for TB exposure.
Evaluate each option based on this purpose:
Does it show duration? No, it's a snapshot of immune reactivity.
Does it confirm active disease? No, it's positive in both active and latent states.
Does it confirm latent disease? No, for the same reason, it can't distinguish from active disease.

Concept Tested & Keywords

QxewUVX92edrYqYB90Gu0C

E6 Parks TextBook of Preventive & Social Medicine part 1 — Subpart B (pp 202-403 of 604) p. 25-27

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 257-259

E6 Pathology-Textbook of PATHOLOGYHarsh Mohan Part 1 (1-214) p. 116-118

Practise the full IGNOU Post B. SC. Nursing entrance-2019

Attempt every question from this paper in a timed mock, then review the full solution for each one.